 Home > Active Ingredient News > Drugs Articles > Yiyi Bio-Long-acting Shengbaiyao submitted a new drug listing application to the EU, and it is expected to be listed at the end of the year in China

Yiyi Bio-Long-acting Shengbaiyao submitted a new drug listing application to the EU, and it is expected to be listed at the end of the year in China

 Last Update: 2021-10-22
 Source: Internet
 Author: User

Tags

sell food online

adenosine drug

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On October 7th, Yifan Pharmaceutical announced that its subsidiary Yiyi Biotech received an acceptance letter from EMA on September 30, 2021, local European time .

On October 7, Yifan Pharmaceutical announced that its subsidiary, Yiyi Biotech, had received an acceptance letter from EMA on September 30, 2021, local European time.

From: Corporate Announcement

This is the second new drug marketing application submitted by F-627 worldwide

According to the announcement of Efan Pharmaceuticals, F-627, as the only non-PEG-modified product, has differentiated advantages

Details of Bergstrom's domestic projects

From: Insight database (http://db.

The G-CSF market is vast

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Tirzepatide Lyophilized powder Vial 5mg 10mg 15mg 20mg 30mg customize 99% Purity with third side checking report

CAS No.: 2023788-19-2

Pharmacy Grade

$50-60/UNIT FOB

Wight loss Lyophilized Semaglutide Petide powder CAS 910463-68-2 with 99.9% purity

CAS No.: 910463-68-2

Pharmacy Grade

$140-175/G FOB

High Quality (E,E,E,E)-Squalene CAS NO 111-02-4 GMP ISO9001 EP Pharma grade Manufacture

CAS No.: 111-02-4

EP Pharma grade

$400-405/KG FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

80 20 company(94)

united states logo(227)

ups united states(221)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.